Company / Depreciation & Amortization
Teladoc Health, Inc. Depreciation & Amortization History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$256.0M
FY2022
5-year range
$204.2M / $256.0M
FY2018-FY2022
Trend
+25.4%
vs FY2021
Sector context
#37 of 135
Health Care
What the data says
At $256M, Teladoc Health, Inc.'s depreciation & amortization ranks #99 of 135 in the Health Care sector. Depreciation & Amortization has increased for 6 consecutive years, from $8M in FY2016 to $256M in FY2022.
Based on SEC 10-K filings.
$256M in FY2022 with a 5-year CAGR of +68.1%.
Increased from $69M to $256M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +87.3%
- 5-Year CAGR
- +68.1%
- 10-Year CAGR
- -
Sector benchmark
#99 of 135 in Health CareTop 73% of 135This company $256.0M Sector average $334.5M
▼
-23.5% below sector average
Key checks
Key Insights
- Teladoc Health, Inc.'s depreciation & amortization has grown for 6 consecutive years.
- 5-year CAGR of +68.1%, indicating consistent growth.
- In FY2022, depreciation & amortization increased 25.4% year-over-year.
- Ranks #37 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $256.0M | +25.4% |
| FY2021 | $204.2M | +193.9% |
| FY2020 | $69.5M | +78.4% |
| FY2019 | $39.0M | +9.4% |
| FY2018 | $35.6M | +86.4% |
| FY2017 | $19.1M | +130.9% |
| FY2016 | $8.3M | +70.1% |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026